Online ISSN: 2515-8260

Keywords : Community-acquired pneumonia


Modern Approaches To The Selection Of Protected Cephalosporins Iii For Therapy Of Community-Acquired Pneumonia In Children

Mukhlisakhon Ravshanhanovna Kurbanova; Furkat Mukhitdinovach Shamsiev; Rano Anvarbekovna Musajavova

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 3, Pages 3008-3014

The aim of the study was to study the effectiveness of the use of protected cephalosporin III generation Extum in the treatment of community-acquired pneumonia in children. The study included 100 children with community-acquired pneumonia at the age from 1 to 15 years, who were observed and treated in the department of pulmonology. In the process of complex clinical and laboratory examination of children, biochemical, microbiological and immunological research methods were used. Microbiological studies have shown that in children with community-acquired pneumonia, S. Pneumonia occupies a significant place in the etiological structure and accounts for 42.0% of cases, a high sensitivity of pneumococcus to injectable cephalosporin of the third generation has been established. When included in complex treatment, protected cephalosporin of the third generation Extum leads to a decrease in the frequency of repeated acute respiratory infections and their complications by 2.2 times, the frequency of recurrent bronchitis and pneumonia by 1.7 times, which indicates a high therapeutic effectiveness of the proposed treatment

Prediction Of Long-Term Results Of Out-OfCommunity-Asquired Pneumonia Depending On The Course Of The Disease

Nosirova Dildora Erkinovna; Mamurova Nigora Normuratovna

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 7, Pages 5030-5036

Pneumonia is a disease that has an acute course and is characterized by an infectious and inflammatory lesion of the lungs. The high level of one-stage morbidity of community-acquired pneumonia, mainly in the variant of severe and life-threatening course in combination with concomitant pathology (75.4%), causes significant damage to the health of the population and deaths are observed in 6.7%. The problem of manifestations of long-term results of pneumonia is becoming increasingly relevant today in connection with the sharply increased rate and intensity of working activity of people, improving the quality of work, as well as environmental pollution and concomitant pathology also leaves its mark on human health. In case of community-acquired pneumonia, the concomitant pathology will influence the long-term results, further observation of these patients will show for 2, 3 years, depending on the severity of the course.